生物巨分子介导的向蛋白质降解:癌症治疗的新兴策略
Meiyang Xi1, Fengxia Zhang2, Jingjing Zhu2
1Zhejiang Engineering Research Center of Fat-soluble Vitamin, Shaoxing University, Shaoxing, 312000, China; College of Chemistry and Chemical Engineering, Shaoxing University, Shaoxing, 312000, China.
European journal of medicinal chemistry
|August 3, 2025
概括
生物大分子合物,包括降解剂-抗体合物 (DAC) 和体-PROTAC合物 (APC),为克服传统癌症化学疗法和化向合物 (PROTAC) 的局限性提供了新的策略. 这些先进疗法旨在提高癌症治疗的疗效和降低癌症治疗中的毒性.
科学领域:
- 生物技术是生物技术.
- 在瘤学瘤学.
- 药物发现 药物发现 药物发现
背景情况:
- 传统化疗面临诸如副作用和耐药性等挑战.
- 蛋白质溶解向嵌合体 (PROTACs) 是有前途的,但具有药理动力学和毒性问题.
- 有针对性的治疗对于提高PROTAC的疗效和最大限度地降低瘤外毒性至关重要.
研究的目的:
- 审查用于癌症治疗的生物巨分子-PROTAC结合物的机制和最近的进展.
- 讨论这些向蛋白质降解策略的当前挑战和未来前景.
主要方法:
- 关于降解剂-抗体合物 (DACs) 和阿巴美尔-PROTAC合物 (APCs) 的科学文献的综述.
- 分析机制,临床进展和临床前发展.
- 讨论工程策略,以改善PROTAC的交付和安全.
主要成果:
- 几种DAC正在进行癌症治疗的临床试验.
- 在临床前研究中,Aptamer-PROTAC合物 (APCs) 显示出更好的组织透和较低的免疫性.
- 生物结合策略旨在克服PROTAC的局限性,例如透性差和毒性.
结论:
- 生物宏分子合物在向癌症治疗中是一个有前途的前沿.
- 需要进一步的研究和开发来应对挑战,并充分发挥APC和其他合物的潜力.
- 这些先进的方法为更有效,更安全的癌症治疗提供了途径.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Regulated Protein Degradation
7.6K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.6K
Protein Networks
4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
The Proteasome
1.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.1K


